Oltipraz
- Generic Name
- Oltipraz
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C8H6N2S3
- CAS Number
- 64224-21-1
- Unique Ingredient Identifier
- 6N510JUL1Y
- Background
Oltipraz has been used in trials studying the treatment and prevention of Lung Cancer, Liver Fibrosis, Liver Cirrhosis, and Non-alcoholic Fatty Liver Disease.
- Associated Conditions
- -
- Associated Therapies
- -
Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver Cirrhosis
- Conditions
- Interventions
- First Posted Date
- 2019-10-29
- Last Posted Date
- 2022-10-06
- Lead Sponsor
- PharmaKing
- Target Recruit Count
- 146
- Registration Number
- NCT04142749
- Locations
- 🇰🇷
Catholic University Bucheon ST. Mary's Hospital, Bucheon, Korea, Republic of
🇰🇷Severance Hospital, Seoul, Korea, Republic of
🇰🇷Gangneung Asan Medical Center, Gangneung-si, Korea, Republic of
Efficacy and Safety of Oltipraz in the Patients With Non-alcoholic Fatty Liver Disease
- First Posted Date
- 2011-06-15
- Last Posted Date
- 2013-12-10
- Lead Sponsor
- PharmaKing
- Target Recruit Count
- 60
- Registration Number
- NCT01373554
- Locations
- 🇰🇷
Seoul National University Hospital, Daehak-ro Jongno-gu, Seoul, Korea, Republic of
🇰🇷Inje University Ilsan Paik Hospital, Dahwa-dong, Ilsanseo-gu, Goyang-si, Gyeonggi-do, Korea, Republic of
🇰🇷Korea University Guro hospital, Gurodong-ro, Seoul, Korea, Republic of
Efficacy and Safety of Oltipraz in the Patients With Liver Fibrosis and Cirrhosis
- First Posted Date
- 2009-08-11
- Last Posted Date
- 2009-08-11
- Lead Sponsor
- HK inno.N Corporation
- Target Recruit Count
- 81
- Registration Number
- NCT00956098
- Locations
- 🇰🇷
The Catholic University of Korea Seoul St. Mary's Hospital, Banpo-Dong, Seocho-Gu, Seoul, Korea, Republic of
🇰🇷The Catholic University of Korea Holy Family Hospital, Sosa-Dong, Wonmi-Gu, Kyungki-Do, Korea, Republic of
Oltipraz in the Prevention of Lung Cancer in People Who Smoke
- Conditions
- First Posted Date
- 2003-05-30
- Last Posted Date
- 2012-06-11
- Lead Sponsor
- Northwestern University
- Registration Number
- NCT00006457
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
🇺🇸Duke Comprehensive Cancer Center, Durham, North Carolina, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.